TARGETING CD46 FOR BOTH ADENOCARCINOMA AND NEUROENDOCRINE PROSTATE CANCER Article Su Y., Liu Y., Behrens C.R., Bidlingmaier S., Lee N.K., Liu B., Aggarwal R., Sherbenou D.W., Shuman M.A., Small E.J., Hann B.C., Simko J.P., Premasekharan G., Paris P.L., Burlingame A.L., Seo Y. JCI Insight. Vol. 3. 2018.
EXPRESSION OF P63 IN ADENOCARCINOMA OF THE LUNG AS A FACTOR OF POOR PROGNOSIS. Article Byakhova M.M., Gurevich L.E., Byakhova V.M. Virchows Archiv-European Journal of Pathology. Springer-Verlag GmbH. Vol. 473. 2018. S340 p.